Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Photodynamic therapy uses a drug that becomes active when it is exposed to a
certain kind of light. When the drug is active, tumor cells are killed. This may be an
effective treatment against skin cancer.
PURPOSE: This phase II trial is studying the side effects of photodynamic therapy using
aminolevulinic acid and to see how well it works in treating patients with skin cancer.